| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0a57261ee9f6aee9305b728e442cb9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6acd7da2bd403f55b0824c2acf5438b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc7e960a5630f80ea0f36d852988fc80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6773764a9d18da6583ddd0f873234890
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67e1aad9cf209e2ac4d9b2789e5d27e4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M15-00 |
| filingDate |
2012-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b014a40040e2753ecf53259fd97119f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee7b676cc8a4b8780f197ddfa448434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_909812a6d8fee83cdee8245fb3f0e61c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2206351579bd75ac7e7efeb406af7832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de92109cb6f744595ea68500cdab0b1f |
| publicationDate |
2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012148641-A1 |
| titleOfInvention |
Methods of treatment of endobronchial infections |
| abstract |
The present invention provides methods for the treatment of an endobronchial infection in a patient by administering to the endobronchial system of the patient a dry powder aerosol composition comprising from 90 to 130 mg of an aminoglycoside antibiotic one to three times a day for a first treatment period of 20 to 36 days. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8715623-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8820323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8826904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008063606-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421166-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603439-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8636984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8636983-B2 |
| priorityDate |
2004-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |